Novartis
NVS
NVS
1,133 hedge funds and large institutions have $20.4B invested in Novartis in 2020 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 423 increasing their positions, 457 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 1,172 → 1,133 (-39)
16% less capital invested
Capital invested by funds: $24.4B → $20.4B (-$3.97B)
21% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 110
Holders
1,133
Holding in Top 10
30
Calls
$158M
Puts
$107M
Top Buyers
| 1 | +$357M | |
| 2 | +$156M | |
| 3 | +$139M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$129M |
| 5 |
FAM
Fred Alger Management
New York
|
+$85.4M |
Top Sellers
| 1 | -$417M | |
| 2 | -$384M | |
| 3 | -$281M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$240M |
| 5 |
Jennison Associates
New York
|
-$217M |